Press Release: Sanofi announces buy back of shares from L’Oréal

Core Viewpoint - Sanofi has announced the acquisition of 2.3% of its shares from L'Oréal as part of its share buyback program, emphasizing its commitment to sustainable value creation for shareholders [1][2]. Group 1: Transaction Details - The acquisition involves 29,556,650 shares at a price of €101.50 per share, totaling €3 billion, which reflects a 2.8% discount to the closing price on January 31, 2025 [2]. - The shares acquired from L'Oréal will be cancelled by April 29, 2025, and the transaction is expected to be accretive to Sanofi's earnings per share [2][3]. - After the cancellation, L'Oréal will own 7.2% of Sanofi, with 13.1% of voting rights [3]. Group 2: Governance and Compliance - The acquisition is structured as an off-market block trade and complies with French Commercial Code regulations, having been approved by Sanofi's Board of Directors [2][4]. - An independent expert, Finexsi, confirmed that the price of the repurchased shares is fair and that the transaction will not adversely affect Sanofi's financial balances [4]. Group 3: Strategic Importance - François Roger, CFO of Sanofi, highlighted the long-standing partnership with L'Oréal and the importance of this transaction in maintaining strategic priorities while enhancing shareholder value [2]. - The transaction underscores Sanofi's focus on sustainable value creation and the preservation of key partnerships [2].